Cover Image
市場調查報告書

更年期熱潮紅的開發中產品分析

Menopausal Hot Flashes - Pipeline Review, H2 2015

出版商 Global Markets Direct 商品編碼 192701
出版日期 內容資訊 英文 58 Pages
訂單完成後即時交付
價格
Back to Top
更年期熱潮紅的開發中產品分析 Menopausal Hot Flashes - Pipeline Review, H2 2015
出版日期: 2015年11月25日 內容資訊: 英文 58 Pages
簡介

所謂熱潮紅,是感覺體溫突然上升的症狀,尤其在更年期更是常見的症狀。尤其會強烈出現在臉、頸部、胸部。主要症狀有心跳數急升、以上半身為中心的發汗、熱潮紅退時突然感到惡寒等。原因有吸煙及缺乏運動、肥胖等。主要治療方法有荷爾蒙療法和抗憂鬱劑等。

本報告提供全球各國治療更年期熱潮紅用的開發中產品開發情形相關分析,提供產品開發·上市的最新趨勢,及臨床實驗各階段的產品一覽,再加上主要企業簡介,主要藥物概要,最新的產業趨勢等資訊。

目錄

簡介

  • 分析範圍

更年期熱潮紅概要

治療藥的開發

  • 更年期熱潮紅開發中產品:概要
  • 更年期熱潮紅開發中產品:比較分析

各企業開發中的更年期熱潮紅治療藥

開發中產品的概要

  • 臨床實驗階段的產品
  • 初期階段的產品
  • 開發階段不明的產品

更年期熱潮紅治療藥:開發中的產品一覽(各企業)

更年期熱潮紅治療藥的開發企業

  • Eisai
  • Concert Pharmaceuticals, Inc.
  • PharmaNova Inc.
  • Intra-Cellular Therapies, Inc.
  • Pherin Pharmaceuticals, Inc.

更年期熱潮紅:治療藥的評估

  • 單劑治療藥的情況
  • 標的別
  • 各作用機制
  • 各投藥法
  • 各分子類型

藥物簡介

  • gabapentinER
    • 產品概要
    • 功能機制
    • 研究開發(R&D)的發展情形
  • RAD-1901
  • PH-80-HF
  • CTP-347
  • Small Molecule For Menopausal Ho
  • homatropine methylbromide

更年期熱潮紅治療藥:開發中產品的最新趨勢

更年期熱潮紅治療藥:暫停開發的產品

更年期熱潮紅治療藥:中止開發的產品

更年期熱潮紅相關產品的開發里程碑

  • 值得注意的最新趨勢·新聞稿(全10件)

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC7386IDB

Summary

Global Markets Direct's, 'Menopausal Hot Flashes - Pipeline Review, H2 2015', provides an overview of the Menopausal Hot Flashes's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Menopausal Hot Flashes, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Menopausal Hot Flashes and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Menopausal Hot Flashes
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Menopausal Hot Flashes and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Menopausal Hot Flashes products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Menopausal Hot Flashes pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Menopausal Hot Flashes
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Menopausal Hot Flashes pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • Menopausal Hot Flashes Overview
  • Therapeutics Development
    • Pipeline Products for Menopausal Hot Flashes - Overview
    • Pipeline Products for Menopausal Hot Flashes - Comparative Analysis
  • Menopausal Hot Flashes - Therapeutics under Development by Companies
  • Menopausal Hot Flashes - Pipeline Products Glance
    • Late Stage Products
    • Clinical Stage Products
    • Early Stage Products
    • Unknown Stage Products
  • Menopausal Hot Flashes - Products under Development by Companies
  • Menopausal Hot Flashes - Companies Involved in Therapeutics Development
    • Amgen Inc.
    • EndoCeutics, Inc.
    • Pantarhei Bioscience BV
    • Pherin Pharmaceuticals, Inc.
    • Pivot Pharmaceuticals Inc
    • Radius Health, Inc.
  • Menopausal Hot Flashes - Therapeutics Assessment
    • Assessment by Monotherapy Products
    • Assessment by Combination Products
    • Assessment by Target
    • Assessment by Mechanism of Action
    • Assessment by Route of Administration
    • Assessment by Molecule Type
  • Drug Profiles
    • (prasterone + acolbifene hydrochloride) - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AMG-334 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • estetrol - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FP-101 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HBN-2 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • homatropine methylbromide - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MNGX-100 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • P-002 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Q-122 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • RAD-1901 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Salubrin-HF - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Menopausal Hot Flashes - Recent Pipeline Updates
  • Menopausal Hot Flashes - Dormant Projects
  • Menopausal Hot Flashes - Discontinued Products
  • Menopausal Hot Flashes - Product Development Milestones
    • Featured News & Press Releases
      • Sep 26, 2012: Eaton Scientific Highlights International Potential For Tropine 3 As Globally Accepted Non-Hormonal Treatment For Hot Flash Symptoms
      • Sep 25, 2012: Eaton Scientific Provides Outline On Market Potential Of Tropine 3 For Non-Hormonal Treatment Of Hot Flashes
      • Sep 13, 2012: Eaton Scientific Teams Up With Urologist Dr Jennifer Berman To Advance Tropine 3 Trials And Marketing
      • Sep 06, 2012: Eaton Scientific Completes Study Protocol For Phase I/II Study Of Tropine 3 For Treatment Of Hot Flashes
      • Sep 04, 2012: Eaton Scientific Enters Agreement With RoxSan Pharmacy To Provide Tropine 3 For Upcoming Clinical Trial Participants
      • Aug 28, 2012: Eaton Scientific Announces Clinical Trial Plans For Tropine 3 For Treatment Of Hot Flashes In Menopausal Women
      • Jun 19, 2010: Radius Presents Positive Phase IIa Study Results Of RAD1901 In Reducing Menopausal Hot Flashes
      • Jun 08, 2008: Radius Presents Preclinical Study Of RAD1901 At The Endocrine Society 2007 Annual Meeting
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Number of Products under Development for Menopausal Hot Flashes, H2 2015
  • Number of Products under Development for Menopausal Hot Flashes - Comparative Analysis, H2 2015
  • Number of Products under Development by Companies, H2 2015
  • Comparative Analysis by Late Stage Development, H2 2015
  • Comparative Analysis by Clinical Stage Development, H2 2015
  • Comparative Analysis by Early Stage Development, H2 2015
  • Comparative Analysis by Unknown Stage Development, H2 2015
  • Products under Development by Companies, H2 2015
  • Menopausal Hot Flashes - Pipeline by Amgen Inc., H2 2015
  • Menopausal Hot Flashes - Pipeline by EndoCeutics, Inc., H2 2015
  • Menopausal Hot Flashes - Pipeline by Pantarhei Bioscience BV, H2 2015
  • Menopausal Hot Flashes - Pipeline by Pherin Pharmaceuticals, Inc., H2 2015
  • Menopausal Hot Flashes - Pipeline by Pivot Pharmaceuticals Inc, H2 2015
  • Menopausal Hot Flashes - Pipeline by Radius Health, Inc., H2 2015
  • Assessment by Monotherapy Products, H2 2015
  • Assessment by Combination Products, H2 2015
  • Number of Products by Stage and Target, H2 2015
  • Number of Products by Stage and Mechanism of Action, H2 2015
  • Number of Products by Stage and Route of Administration, H2 2015
  • Number of Products by Stage and Molecule Type, H2 2015
  • Menopausal Hot Flashes Therapeutics - Recent Pipeline Updates, H2 2015
  • Menopausal Hot Flashes - Dormant Projects, H2 2015
  • Menopausal Hot Flashes - Dormant Projects (Contd..1), H2 2015
  • Menopausal Hot Flashes - Discontinued Products, H2 2015

List of Figures

  • Number of Products under Development for Menopausal Hot Flashes, H2 2015
  • Number of Products under Development for Menopausal Hot Flashes - Comparative Analysis, H2 2015
  • Number of Products under Development by Companies, H2 2015
  • Comparative Analysis by Clinical Stage Development, H2 2015
  • Assessment by Monotherapy Products, H2 2015
  • Number of Products by Targets, H2 2015
  • Number of Products by Stage and Targets, H2 2015
  • Number of Products by Mechanism of Actions, H2 2015
  • Number of Products by Stage and Mechanism of Actions, H2 2015
  • Number of Products by Routes of Administration, H2 2015
  • Number of Products by Stage and Routes of Administration, H2 2015
  • Number of Products by Molecule Types, H2 2015
  • Number of Products by Stage and Molecule Types, H2 2015
Back to Top